AstraZeneca subpoenaed
Executive Summary
The Boston U.S. Attorney's office issues subpoena to AstraZeneca as part of an investigation related to sales and marketing practices to a physician's office in Worcester, Mass., company says in a Securities & Exchange Commission 1filing. This investigation is separate from another Boston U.S. Attorney investigation into Prilosec promotions to New England Medical Center (2"The Pink Sheet" March 3, 2003, p. 3)...
You may also be interested in...
AstraZeneca Nexium Marketing Draws FTC Scrutiny; DoJ Looking At Prilosec
The Federal Trade Commission is investigating AstraZeneca's marketing of the omeprazole follow-on product Nexium
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.